review

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026

May 17, 2026 16:00 ET  | Source: Design Therapeutics, Inc. CARLSBAD, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics,…

2 days ago

KuCoin Releases $2B Trust Project Annual Review, Marking Major Milestones in Security, Compliance, Transparency and User Protection

PROVIDENCIALES, Turks and Caicos Islands, May 15, 2026 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today…

4 days ago

SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints

Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…

3 weeks ago

Privacy-led UX is becoming a prerequisite for AI adoption, new MIT Technology Review Insights report finds

Organizations that treat consent as an ongoing data relationship—not a one-time transaction—are better positioned to build trust, improve data quality,…

1 month ago

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be earned if you purchase through links in this…

1 month ago

New Vitality, New Momentum: Xi’an’s 2025 Economic Review and Future Growth Prospects

Charting Xi'an's 2026 Vision: Driving Innovation-Led Transformation and High-Quality Development in Western ChinaXI'AN, China, March 10, 2026 /PRNewswire/ -- As…

2 months ago

International Fleet Review 2026 to Showcase India’s Naval Diplomacy and Maritime Partnerships

The Indian Navy is set to host the International Fleet Review 2026 (IFR) at VisakhapatnamVISAKHAPATNAM, India , Feb. 5, 2026 /PRNewswire/…

3 months ago

HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate

PANAMA CITY, Jan. 28, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global investment arm of HTX, released its latest research…

4 months ago

FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…

4 months ago

HTX’s 2025 Listing Strategy Review, Building a High-Liquidity Ecosystem Through First-Mover Advantage and Longtermism

PANAMA CITY, Jan. 23, 2026 /PRNewswire/ -- In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection…

4 months ago